PAVmed Inc.
PAVM
$9.11
-$0.22-2.36%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -97.63% | -99.28% | -73.36% | -33.92% | 22.15% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -97.63% | -99.28% | -73.36% | -33.92% | 22.15% |
| Cost of Revenue | -95.52% | -97.19% | -77.85% | -54.08% | -24.64% |
| Gross Profit | 92.08% | 93.62% | 83.64% | 70.08% | 53.54% |
| SG&A Expenses | -52.51% | -61.94% | -49.97% | -33.16% | -25.51% |
| Depreciation & Amortization | -- | -100.00% | -94.49% | -90.09% | -72.33% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -53.92% | -66.14% | -55.96% | -42.11% | -33.36% |
| Operating Income | 50.98% | 63.74% | 54.85% | 42.50% | 35.34% |
| Income Before Tax | -108.69% | -85.52% | 193.89% | 186.77% | 135.86% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -108.69% | -85.52% | 193.89% | 186.77% | 135.86% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -74.74% | -88.48% | -68.16% | -40.39% | -24.69% |
| Net Income | -98.99% | -87.28% | 226.20% | 220.36% | 162.00% |
| EBIT | 50.98% | 63.74% | 54.85% | 42.50% | 35.34% |
| EBITDA | 49.86% | 62.78% | 53.64% | 40.91% | 34.28% |
| EPS Basic | -90.48% | -41.54% | 186.77% | 173.07% | 129.64% |
| Normalized Basic EPS | 91.99% | 92.46% | 84.38% | 74.57% | 67.01% |
| EPS Diluted | 65.19% | 83.79% | 112.60% | 106.37% | 74.23% |
| Normalized Diluted EPS | 94.67% | 97.14% | 96.07% | 84.55% | 73.97% |
| Average Basic Shares Outstanding | 107.79% | 79.35% | 58.37% | 40.86% | 33.76% |
| Average Diluted Shares Outstanding | -38.72% | 218.44% | 640.77% | 664.33% | 571.53% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |